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Formation of immunological synapses (IS) between dendritic cells (DCs) and conventional
CD4+ T cells (Tcon) is critical for productive immune responses. However, when DCs are
HIV-infected such synapses are critical to establish HIV infection. As regulatoryT cells (Treg)
control DC–Tcon interactions, we inquired whether Treg might interfere with DC to Tcon
HIV infection. We developed a model, using monocyte-derived DC infected with R5-HIV,
and cultured withTcon in the presence or absence of autologousTreg, using the physiologi-
cal ratio of 1Treg for 10Tcon. Cultures containingTreg significantly decreased HIV infection
in DC:T cell clusters. Notably, Treg appear to have an effect on the quality of the IS, as
Treg decreased actin polymerization and DC maturation. Importantly, Treg decreased the
trafficking of HIV punctate to the IS. Further, CD152 and cyclic adenosine monophosphate
were criticalTreg effector molecules, as their individual or simultaneous blockade abolished
Treg activity, however no additive effect was found. Together, these data suggest that Treg
can reduce HIV dissemination, which may be beneficial to the host in the early stages of
infection.
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INTRODUCTION
Dendritic cells (DCs) constitute an important cellular targets
for HIV. In particular, they are amongst the first target cells
to encounter the virus at mucosal surfaces. DC can be directly
and productively infected by HIV (1), and the newly generated
HIV virions can infect other target cells through a process called
cis-infection (2). Myeloid DCs are particularly sensitive to CCR5-
using virus infection (3). Additionally, DCs can transmit virus
to CD4+ T cells, without being themselves productively infected,
through a process called trans-infection (4). HIV induces partial
maturation of DC, which leads to their migration to the draining
lymph nodes (5). Thus, DC harboring HIV mediates the spread
of HIV to CD4+ T cells in a more efficient manner than cell-
free virus (6). Similarly, DC:Tcon clusters are the main focus of
infection in vitro (7). Consequently, the frequency and quality of
DC–CD4+ T cell interactions plays a critical role in the efficiency
of HIV transmission and spread.
Importantly, one of the mechanisms that can affect these inter-
actions is regulatory T cells (Treg). Treg limit DC:T cell interactions
by decreasing both DC maturation and T cell activation (8).
Among the mechanisms used by Treg to suppress DC matura-
tion, previous studies have implicated CD152 (CTLA-4) and cyclic
adenosine monophosphate (cAMP) (9, 10).
We and others have reported a rapid increase in Treg frequency
in all immune compartments of HIV-infected individuals (11,
12), which start during acute infection (13). We and others have
recently shown that Treg can reduce the infection of conventional
T cells and macrophages in vitro (14, 15). Interestingly, decreased
infection of macrophages consequently attenuated HIV-associated
neurodegeneration (14). However, the effect exerted by Treg on
DC-mediated HIV infection of conventional CD4+ T cells (Tcon)
has not yet been reported.
In the present study, we show that Treg significantly, albeit mod-
estly, decreased HIV infection in DC:Tcon clusters. Our results also
indicate that DC are the main targets of Treg, with a clear reduction
of actin polymerization at the immunological synapse (IS), asso-
ciated with a modest decrease of DC maturation. Treg decreased
the mobilization of HIV punctate to the IS potentially due to
their effect on actin polymerization. Mechanistically, individual
or combined blockade of either cAMP or CTLA-4 was sufficient
to abolish the Treg effect, however no additive effect was found.
MATERIALS AND METHODS
HUMAN SUBJECTS
Blood samples from healthy HIV-negative adult subjects, recruited
by the Hoxworth Blood Bank (Cincinnati, OH, USA), were used
in this study. Because the samples were not collected for research
purpose and were de-identified, the University of Cincinnati Insti-
tutional Review Board had determined this activity to be exempted
from IRB review and surveillance.
CELL ISOLATION AND CULTURE
Peripheral blood mononuclear cells (PBMCs) were separated
by centrifugation over Ficoll-Hypaque (GE, Fairfield, CT, USA).
CD14+ monocytes were isolated by positive selection (CD14
beads, Miltenyi Biotec, Auburn, CA, USA) and immature
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monocyte-derived DCs were generated by culturing the isolated
monocytes for 4 days in complete medium (RPMI 1640, supple-
mented with 10% of heat-inactivated fetal calf-serum, HEPES,
Glutamine) with 500 U/ml rhIL-4 and 1,000 U/ml rhGM-CSF
(both from PeproTech, Inc., Rocky Hill, NJ, USA). Complete
medium, including cytokines, was replaced at day 3. After 4 days
of differentiation, cells had the morphology of immature DCs
(CD14low and HLA-DRhi expression; no adherence to the culture
plate). Resting autologous CD4+ T cells were purified by neg-
ative selection using the Miltenyi CD4 separation kit (Auburn,
CA, USA), according to the manufacturer’s instructions. Puri-
fied CD4+ T cells were then stained with anti-CD8-FITC, anti-
CD25-APC (BD Pharmingen; San Diego, CA, USA), and anti-
CD127-PE (Beckman Coulter, Fullerton, CA, USA), to separate
Treg and Tcon by cell sorting (FACSAria, BD). The purity of Treg
(CD8negCD25hiCD127low) and Tcon (CD8negCD25lowCD127hi)
cells was evaluated post-sorting by CD4 and FOXP3 staining (clone
PCH101, e-Bioscience; San Diego, CA, USA). Purity of the sorted
populations was superior or equal to 90% (data not shown).
VIRUS PRODUCTION AND DC INFECTION
The BaL HIV virus was obtained from the NIH AIDS Research
and Reference Reagent Program. Simian Immunodeficiency Virus
(SIVmac)-virion like-particles (VLPs) were obtained from Dr.
Andrea Cimareli (Ecole Normale Supérieure, Lyon, France), as
described (16). R5-tropic iGFP-JRFL HIV was obtained from
Dr. Benjamin Chen (Mount Sinai Medical School, NY, USA), as
described (17). 293 T cells were transfected with plasmids encod-
ing either VLPs or complete iGFP-JRFL HIV, using the FuGENE
transfection technology (Roche) according to the manufacturer’s
protocol. After 2 days, supernatants were harvested, and viruses
were concentrated using 100 K filtration systems (Millipore). BaL
and iGFP-JRFL were titrated using the TZM-bl indicator cell line.
VLP titers were determined using the Reverse Transcriptase col-
orimetric assay kit (Roche). Immature DCs were infected at a
multiplicity of infection (MOI) of two. Briefly,DCs were incubated
with HIV (BaL or iGFP-JRFL) plus SIVMAC-VLPs for 2 h at 37°C,
plated at 0.5× 106 per well in 1 ml of complete media and cultured
for 3 days to allow for productive infection. In experiments with
iGFP-JRFL viruses, cell sorting was used to enrich infected DCs,
based on their GFP expression (FACSAria, BD). In some experi-
ments, DCs were treated with Zidovudine (AZT, 1µM) at the time
of HIV infection to inhibit productive infection.
CO-CULTURE OF DC, Tcon, AND Treg
After 3 days of infection, DCs were washed twice with complete
RPMI and co-cultured for 24 h with autologous Tcon stained with
0.3µM carboxyfluorescein diacetate succinimidyl ester (CFSE;
Molecular Probes; Eugene, OR, USA), in the presence or absence of
autologous Treg stained with Calcein AM Blue (Molecular Probes).
Ratios of 1 DC, 10 Tcon, and 1 Treg were used. For the experiments
using DC infected with iGFP-JRFL, Tcon were stained with Cell
trace Violet (Molecular Probes). Co-cultures were carried out for
36 h, to evaluate the effect of Treg on viral trafficking from DC to
Tcon. This time was chosen after kinetics studies, because the virus
was found in DC, IS, and Tcon at that time, while the numbers of
DC:T cell clusters remained high.
BLOCKADE OF Treg ACTIVITY
In some experiments, co-cultures were performed in presence
of blocking anti-human CD152 (CTLA-4, 10µg/ml, clone BNI3,
Beckman Coulter). In other experiments, Treg were pre-treated for
24 h with 2′,5′-Dideoxyadenosine (ddADA), an inhibitor of adenyl
cyclase (200µM, Sigma). Treg were then extensively washed to
avoid a direct contact of ddADA with the DC and Tcon. In addi-
tion, simultaneous blockade of both pathways was performed in
some experiment.
FLOW CYTOMETRY ANALYSIS OF HIV-p24GAG LEVELS, DC MATURATION,
AND T CELL ACTIVATION MARKERS
Cells in co-cultures were harvested, treated with 20µg/ml of
human IgG to block Fc receptors, and stained with anti-HLA-DR
eFluor450 (Clone L243; eBiosciences, San Diego, CA, USA), anti-
CD80 AF-647 (Clone MEM-233, AbD Serotec, Raleigh, NC, USA),
anti-CD83 PE-Cy7 (Clone HB15e, eBiosciences), anti-CD86 AF-
647 [Clone 2331 (FUN-1), BD; San Diego, CA, USA], anti CD40-
APC-H7 (Clone 5C3, BD), anti-CD25 AF700 (Clone M-A251,
BD), anti-CD69 PE-Cy7 (Clone FN50, Biolegend, San Diego, CA,
USA), anti-CD134 PerCP-Cy5.5 (Clone ACT35, Biolegend), and
Live/Dead® Fixable Aqua Dead Cell Stain Kit (Invitrogen) for
30 min at room temperature in PBS containing 2% fetal calf-
serum and 0.1% sodium azide. Cells were then washed, fixed with
2% formaldehyde for 30 min at 4°C, and stained with anti-HIV-
p24Gag PE (Clone KC-57; Beckman Coulter), in 0.3% saponin
buffer for 30 min at 4°C. A minimum of 100,000 events were
acquired for each sample and analyzed on a LSRII (BD), using the
DIVA software. Live cells were gated based on forward- and side-
scatter properties and the absence of fluorescence in the Live/Dead
Viability Assay. Tcon were identified based on CFSE expression,
DCs were gated on the expression of HLA-DR, and clusters were
gated based on forward-scatter and double expression of CFSE
and HLA-DR.
DETERMINATION OF Tcon:DC CLUSTERS AND ACTIN POLYMERIZATION
AT THE IS BY IMAGING FLOW CYTOMETRY
DC:Tcon:Treg co-cultures were harvested, treated with 20µg/ml
of human IgG, and stained with anti-HLA-DR PerCP (Clone
L243, BD) for 30 min at 4°C. Cells were then fixed with 2%
methanol-free formaldehyde for 30 min, washed, and stained with
Phalloidin AF-647 in 0.3% saponin for 30 min at 4°C. At least
50,000 events/sample were acquired on the ImageStream (Amnis,
EMD Millipore) and analyzed using the IDEAS Software version
5.0. To evaluate the number of Tcon interacting with each DC
in each cluster, the number of CFSE+ cells per HLADR+ cell was
quantified using the Spot count feature. To quantify the actin poly-
merization at the IS, we used the interface mask. We calculated
the intensity of actin within the interface, as well as that in the
overall DC cluster. In each sample, we analyzed only the clusters
in which it was possible to position a IS mask without ambi-
guity (~100 events/sample). Data were normalized based on the
total actin intensity in the overall cluster. Data are calculated with
the following formula (actin intensity at the interface mask/total
actin). As control for actin polymerization, cells were treated with
Cytochalasin D (20µM, Sigma) at the time of co-culture.
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DETERMINATION OF iGFP-HIV VIRAL TRAFFICKING BY IMAGING FLOW
CYTOMETRY
Co-cultures were harvested 36 h after initiation, treated with
20µg/ml of human IgG and stained with anti-HLA-DR BV570
(Clone L243, Biolegend) for 30 min at 4°C. Cells were then fixed
with 2% methanol-free formaldehyde for 30 min, washed, and
stained with phalloidin AF-647 in 0.3% saponin for 30 min at
4°C. At least 50,000 events were acquired for each sample and
analyzed using the IDEAS Software version 5.0. To evaluate the
HIV migration to the IS, we first quantified the iGFP-HIV inten-
sity at the synapse divided by the total iGFP-HIV intensity. Sec-
ond, we quantified the actin intensity at the interface divided by
the total actin staining. Third, we plotted these two features to
track the co-localization of HIV with polymerized actin at the IS.
In some experiments, DCs were treated with Zidovudine (AZT,
1µM) at the time of HIV infection to confirm HIV infection.
In addition, cells were treated with Cytochalasin D (20µM) or
Nocodazole (100µM) at the time of co-culture, as control of actin
polymerization and viral movement.
CYTOKINE QUANTIFICATION IN CULTURE SUPERNATANTS
IL-2, IL-6, IL-10, IL-12p40, TNF-α, and IFN-γ levels were quan-
tified in the 24 h co-culture supernatants using Luminex assays
(Millipore, Billerica, MA, USA).
STATISTICAL ANALYSIS
Statistical analyses were performed using Prism (GraphPad Soft-
ware 5). Paired t -tests were used to compare different culture
conditions. A p value of ≤0.05 was considered to be significant.
Correlations coefficient and r were calculated using Pearson cor-
relation. To compare the correlation coefficients, we used the
method reported by http://core.ecu.edu/psyc/wuenschk/docs30/
CompareCorrCoeff.pdf .
RESULTS
Treg DECREASE THE FREQUENCY OF DC:Tcon CLUSTERS WITH
EVIDENCE OF PRODUCTIVE HIV INFECTION
To test the hypothesis that Treg can control HIV infection of
DC:Tcon clusters, we used an in vitro model of cis-infection
where HIV-infected DCs were cultured with autologous Tcon in
the presence of anti-CD3 to induce IS formation. Importantly,
the Treg:Tcon ratio we used (1:10) is similar to the proportion
found in lymphoid tissues. Tcon were labeled with CFSE before the
co-culture and, after 24 h of co-culture, HLA-DR expression was
used to identify the DC. Using imaging flow cytometry, DC:Tcon
clusters were identified by their dual expression of CFSE and HLA-
DR. The isolated Tcon and the DCs were identified by the single
expression of CFSE or HLA-DR, respectively. Morphology of the
cells confirmed that this analysis strategy was correct (Figure 1A).
Using the same gating strategy in classic flow cytometry led to
similar frequency of CFSE+HLA-DR+ clusters (Figure 1B, left
panel). Additionally, we looked at several DC markers, and, as
shown in Figure 1B, DC:Tcon clusters (red histograms) highly
expressed CD83, CD86, and CD40, at levels comparable to those of
DC alone (orange histograms), while isolated Tcon (CFSE+HLA-
DR−, green histograms) did not express these molecules. Some
FIGURE 1 | Analysis of DC:Tcon clusters using a combined imaging
and classic flow cytometry strategy. DC were infected with HIVBaL for
3 days and cultured with CFSE-labeled Tcon for 24 h at a 1:10 ratio.
(A) Using imaging flow cytometry ImageStream), DC:Tcon clusters were
identified by the expression of CFSE and HLA-DR. Isolated Tcon were
CFSE+HLADR− (green gate), isolated activated Tcon were
CFSE+HLADRdim (blue gate), DC:Tcon were CFSE+HLADR+ (red gate),
and isolated DC are CFSE-HLADR+ (orange gate) populations. DC:Tcon
clusters were found only in the CFSE+LADR+ population. (B) Flow
cytometry analysis of CD83, CD86, CD40, and HLA-DR expression in
isolated Tcon (CFSE+HLADR−; green histograms), isolated semi activated
Tcon (CFSE+HLADRdim; blue histograms), DC:Tcon (CFSE+HLADR+; red
histograms), and isolated DC (CFSE−HLADR+; orange histograms)
populations.
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FIGURE 2 | Infection of DC:Tcon clusters is decreased byTreg, but
infection of isolatedTcon or DC remains unchanged. DCs were
infected with HIVBaL for 3 days and cultured with CFSE-labeled Tcon for
24 h at a 1:10 ratio. (A) After exclusion of dead cells, the percentage of
HIV-p24Gag+ cells was measured in the gated Tcon (CFSE+HLADR−/dim),
DC:Tcon (CFSE+HLADR+), and DC (CFSE−HLADR+) populations. (B) Treg
were added or not to DC:Tcon cultures at a 1:10:1 (DC:Tcon:Treg) ratio
and co-cultured for 24 h. After exclusion of dead cells, the percentage of
HIV-p24Gag+ in clusters, single Tcon, or single DC was analyzed by flow
cytometry using the gating strategy described in (B). Cultures containing
AZT were used to set up the HIV-p24Gag+ gate. One representative
experiment is shown. Percentage of HIV-p24Gag+ cells is indicated in
each panel. UI, uninfected; INF, infected. (C–E) Summary of all
experiments (n=12). (C) DC:Tcon clusters, (D) single Tcon, and (E) single
DC. Normalized HIV infection was calculated based on the DC:Tcon
cultures without Treg for each individual. Mean (SE) percent infection in
DC:Tcon clusters, Tcon, and DC are shown. p Values correspond to paired
t -tests.
CFSE+ cells were expressing low levels of HLA-DR, and could
be activated Tcon. Confirming that it was the case, expression
of CD83, CD86, and CD40 by these CFSE+HLA-DRlow cells was
lower than those observed in the DC:Tcon clusters (blue his-
tograms, Figure 1B). They also had a typical T cell morphology
(Figure 1A). Together, these analyses established that the gating
based on CFSE and HLA-DRhi expression consistently identified
DC:Tcon clusters, and not activated Tcon or Tcon:Tcon clusters.
As shown in Figure 2A, HIV infection mainly occurred
in the DC:Tcon (CFSE+HLADR+) clusters (mean percentage
of infection: 3.9± 0.5%), compared to either isolated Tcon
(CFSE+HLADR−, mean percentage of infection: 0.8± 0.3%), DC
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FIGURE 3 | RegulatoryT cells do not decrease formation of DC:Tcon clusters nor their composition. (A) Cluster frequency in the absence and presence
of Treg was quantified by flow cytometry (n=6). p Value corresponds to a paired t -test. (B) Number of Tcon in each DC:Tcon cluster was quantified by imaging
flow cytometry, in the absence and presence of Treg using a spot count analysis (n=925–1,115/condition). One representative experiment of 2 is shown.
(CFSE−HLADR+, mean percentage of infection: 2.4± 0.6%), or
the CFSE−HLADR− population (mean percentage of infection:
0.9± 0.2%). As expected (18), there was a significant variability
among donors and the infection in the clusters ranged from 1.6
to 8%. Addition of Treg significantly decreased the percentage
of infected DC:Tcon clusters (p= 0.001, Figure 2B shows a rep-
resentative experiment and Figure 2C displays the summary of
12 independent experiments). This decrease was seen in all indi-
viduals we studied. In contrast, infection level of isolated Tcon
or DC was not changed by Treg (p= 0.36 and p= 0.38, respec-
tively, Figures 2D,E), suggesting that DC:Tcon clusters are the
main targets of Treg suppression at this early time point. Of note,
the effect of Treg on HIV infection was not due to enhance-
ment of HIV infection by co-infection with VLP, because Treg
also decreased infection in DC:clusters when DCs were infected
with BaL alone (Figure S1 in Supplementary Material). Treg could
also form aggregates with DC. Infection frequency in these aggre-
gates was 3.4± 2.8%, which was similar to that of DC:Tcon
clusters (p= 0.45). Treg infection might account for decreased
Tcon infection, due to possible competition for access to infected
DCs. Such mechanism would be suggested by an inverse correla-
tion between frequency of infected DC:Treg clusters and that of
infected DC:Tcon aggregates. However,no such correlation existed
(r = 0.34 and p= 0.19).
Treg DO NOT ALTER DC:Tcon CLUSTER FORMATION OR Tcon
ACTIVATION BUT MODESTLY DECREASED DC MATURATION
Regulatory T cells have previously been shown to impair T cell
activation by decreasing the interaction and contact time between
CD4+ T cells and DC when high Treg:Tcon ratios (1:1) were
used (8, 19). At the more physiological frequency we used (1:10
Treg:Tcon), Treg did not impair the formation of DC:Tcon clusters
(Figure 3A). Next, we evaluated by flow cytometry whether Treg
changed the composition of DC:Tcon clusters. Most DC interacted
with 2 Tcon (Figure 3B) and the presence of Treg did not affect
the number of Tcon that interacted with each DC.
Regulatory T cells can decrease CD4 activation and DC matu-
ration (8, 20), which could explain decreased HIV infection in the
presence of Treg. Although Treg significantly decreased the levels of
expression of CD40 and CD83 by DC (both p= 0.01), they did not
diminish their expression of CD80 and CD86 (Table 1). It must be
noted that this effect was modest as the DC still expressed high lev-
els of all the co-stimulatory molecules in presence of Treg. Treg did
not affect the expression of CD25 and CD134 by Tcon (Table 1).
Additionally, Treg did not alter the levels of IL-6, IL-2p40, IL-
10, IL-2, TNF-α, and IFN-γ in the DC:Tcon culture supernatants
(data not shown). Importantly, the effect of Treg on DC matura-
tion was not due to the fact that DCs were infected with both BaL
and VLP, because Treg also decreased DC maturation when DCs
were infected with BaL alone. Indeed, decrease in CD40 MFI due
to the presence of Treg (mean delta CD40 MFI) was 4,390± 1,193
in absence of VLP, compared to 4,061± 1,210 in their presence.
Treg similarly decreased CD83 MFI in the presence or absence of
VLP (mean delta CD83 MFI was 3,029± 2,818 in absence of VLP,
compared to 2,173± 3,603 in their presence).
ACTIN POLYMERIZATION AT THE IS IS SIGNIFICANTLY DECREASED IN
PRESENCE OF Treg
We next investigated whether Treg interfered with the formation
of a stable IS, because it constitutes a critical step for viral dissemi-
nation to T cells. In particular, actin polarization at the IS plays an
important role in cell-to-cell viral spread (21). We visualized actin
polymerization in the DC:Tcon clusters by imaging flow cytom-
etry. Cytochalasin D treatment abolished actin polymerization at
the IS, which confirms the validity of our analysis (Figure S2 in
Supplementary Material). As shown in Figure 4A (lower panel),
we quantified polymerized actin at the IS. Treg significantly, albeit
modestly, decreased IS actin polymerization (Figure 4B). The
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effect of Treg on actin polymerization at the IS was not due to
the presence of VLP, because Treg similarly decreased actin poly-
merization at the IS when DCs were infected with BaL alone (not
shown). Treg effect on actin polymerization was not due to the fact
that more cells where bound to the DC, because when we restricted
our analysis to aggregates that contain only one Tcon per DC, Treg
also significantly decreased actin polymerization (p= 0.01).
HIV PUNCTATE LOCALIZATION IN DC:Tcon CLUSTERS IS ALTERED BY
THE PRESENCE OF Treg
We next investigated whether Treg affected the mobilization of
HIV toward the IS. We used the GFP-expressing CCR5 virus
Table 1 | DC andTcon phenotype.
DC INF:Tcon DC INF:Tcon+Treg pValue#
DC PHENOTYPE
CD80a 3,799 ± 1,152 4,186 ± 1,226 0.07
CD83 15,193 ± 1,991 12,287 ± 2,041 0.01
CD86 64,219 ± 12,354 58,695 ± 9,427 0.81
CD40 37,257 ± 3,403 33,446 ± 3,306 0.01
Tcon PHENOTYPE
CD25 4,450 ± 958 3,960 ± 864 0.25
CD134 6,153 ± 1,441 6,071 ± 1,588 0.46
aValues are expressed as mean MFI±SEM (n=10).
#p Values correspond to paired t-test.
JRFL to infect DC and evaluated viral distribution in the GFP+
DC:Tcon clusters. HIV staining has a punctate pattern as previ-
ously described (17), which allowed quantification of its cellular
localization in the clusters (Figure 5A). Treatment of DC with
AZT before infection confirmed that this punctate staining was
newly generated HIV viruses (Figure 5A, right upper panel).
To validate our experimental system, co-cultures were treated
with Cytochalasin D and Nocodazole, which inhibit actin and
microtubule polymerization, respectively. As shown in Figure 5A
(middle panels), Cytochalasin D and Nocodazole both inhibited
HIV movement to the IS as reported (22). When we analyzed
HIV localization, we found HIV mainly in DC and at the IS
(Figure 5A lower panels). About 50% of the punctate was located
in the DC, followed by around 25% at the IS, and only 20% of
the virus was in the Tcon (data not shown). Notably, the pres-
ence of Treg decreased the number of punctate present at the IS,
but did not change the total number of punctate present in the
aggregates (Figure 5B), suggesting that Treg mainly alter viral dis-
tribution. Particularly, actin polymerization and HIV-iGFP local-
ization at the IS were positively correlated in the DC:Tcon clusters
(p≤ 0.0001, Figure 5B upper panel). When Treg were present
in the culture, this correlation still existed (r = 0.28, p= 0.01,
Figure 5C lower panel), but the strength of association was lower.
We formally tested whether Treg affected this localization by
comparing the correlation coefficient of these two sets of data
(method developed by R. A. Fisher) and found a significant dif-
ference (p= 0.02), suggesting that Treg decreased viral movement
toward the IS.
FIGURE 4 | RegulatoryT cells decrease actin polymerization at the
immunological synapse in DC:Tcon clusters. The actin polymerization at
the IS was quantified using interface mask. Intensity of actin within the
interface was calculated, as well as that in the overall DC cluster. Data are
expressed as a ratio of actin in the IS divided by the total actin intensity in the
cluster. (A) The upper panel shows actin polymerization at IS in one DC:1 Tcon
and one DC:2 Tcon cluster middle panel, the lower panel shows actin
polymerization in the DC:Tcon IS in a DC:Tcon:Treg cluster. (B) Summary of
11 independent experiments, comparing actin polymerization in the absence
and presence of Treg. p Value corresponds to a paired t -test.
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FIGURE 5 | HIV localization in DC:Tcon clusters is altered by the
presence ofTreg. DCs were infected with HIV JRFL iGFP-expressing and
enriched by cell sorting. DC:Tcon:Treg were co-cultured for 24 h in the
presence or not of AZT (1µM) or Cytochalasin D (20µM) or Nocodazole
(100µM). (A) Upper panel shows the uninfected cells (UI) and the
AZT-treated cultures. Tcon were labeled with Cell Violet Tracer (violet) and
DCs were stained for HLA-DR (red). Middle panel shows the effect of
Cytochalasin D and Nocodazole on HIV localization (indicated by white
arrows). Lower panel shows HIV-iGFP in DC:Tcon clusters localized either at
the IS (left) or inside the DC (right). (B) Summary of three independent
experiments, comparing number of punctate at the IS or DC in the absence
and presence of Treg. p Value corresponds to a paired t -test. (C) HIV
migration to the IS was assessed first by quantifying the iGFP-HIV intensity
at the synapse divided by the total iGFP-HIV intensity. Second, we quantified
the actin intensity at the interface divided by the total actin staining as
described in Figure 4. Third, we plotted these two parameters to track the
co-localization of HIV with polymerized actin at the IS. Correlation of actin
polymerization and HIV-iGFP localization in DC:Tcon clusters in the absence
and presence of Treg. Correlation coefficients of the two data sets were
compared (p=0.02).
Treg-MEDIATED DECREASE OF VIRAL INFECTION IN DC:Tcon CLUSTERS
IS MEDIATED BY THEIR CTLA-4 OR cAMP ACTIVITY
CTLA-4 and cAMP are mechanisms used by Treg to control DC
interactions with Tcon or CD8+ T cells (23, 24). We therefore
tested the involvement of these mechanisms in Treg activity by
blocking simultaneously these two effector molecules. To assure
that the blockade principally affected Treg function, we verified
that the anti-CTLA Ab did not affect HIV infection in the clusters
in absence of Treg (data not shown). Similarly, Treg but not DC or
Tcon, were in contact with ddADA, because ddADA-treated Treg
were extensively washed before co-culture. Importantly, blockade
of both CTLA-4 and cAMP resulted in significant inhibition of
Treg capacity to suppress HIV infection (Figure 6). Individual
blockade of either cAMP or CTLA-4 was sufficient to abolish the
Treg effect (Figure 6); however no additive effect was found.
DECREASED ACTIN POLYMERIZATION AND DC MATURATION BY Treg
ARE THE MECHANISMMOST ASSOCIATED WITH THEIR EFFECT ON HIV
REPLICATION
To determine which mechanism is contributing to Treg-mediated
decrease of viral infection, we analyzed in parallel the effect of
combined CTLA-4 and cAMP blockade on HIV replication, actin
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polymerization in the IS, DC maturation, and Tcon activation.
As shown in Figures 7A–C, while the presence of Treg decreased
HIV infection, actin polymerization at the IS, and DC matu-
ration, it did not block Tcon activation. In addition, blockade
of CTLA-4 and cAMP reversed Treg effect on HIV infection,
actin polymerization in the IS (Figure 7A), and CD83 expres-
sion (Figure 7B). Together, these data thus suggest that the effect
of Treg on cytoskeleton rearrangement and DC maturation are the
most strongly associated with their effect on HIV infection.
DISCUSSION
Understanding the immunological mechanisms that underlie
HIV progression remains of essential importance. The earliest
FIGURE 6 | RegulatoryT cells-mediated suppression of viral infection is
mediated by their CTLA-4 or cAMP activity. DC:Tcon:Treg were
co-cultured for 24 h in the presence or not of anti-CTLA-4 blocking antibody.
Treg previously treated with an inhibitor of adenyl cyclase (ddADA) were
added or not to DC:Tcon co-cultures. Percentage of HIV-infected Tcon in
clusters was normalized based on corresponding cultures without Treg.
Effect of individual CTLA-4 or cAMP and combined CTLA-4/cAMP blockade
are shown. Mean and SE are shown (n=12).
interactions of the virus with its cellular targets are of particular
relevance because these events will affect subsequent set points.
DCs are amongst the first target cells to encounter the virus at
mucosal surfaces (25, 26). It is also well established that DC facil-
itate HIV dissemination to the lymphoid organs by enabling HIV
infection of CD4+ T cells (27, 28). Therefore, studying the mech-
anisms that control DC-mediated viral transmission is critical
to our understanding of HIV infection. Although the biologi-
cal effect of Treg during HIV infection remains uncertain, Treg
have been shown to accumulate during HIV infection (3, 11, 13,
29) and to alter DC–T cells interactions [reviewed in Ref. (30)].
This Treg accrual could thus control DC-mediated transmission
of HIV to CD4+ T cells, similar to their effect on HIV infection in
macrophages and CD4+ conventional T cells (14, 15).
To address this question, we developed an in vitro model in
which we could study how Treg affect viral infection of DC:Tcon
clusters. An important characteristic of our model is that we
used a ratio of 1:10:1 DC:Tcon:Treg, which mimics the frequency
encountered in tissues (19). We used a R5 strain to infect the DC,
as R5 viruses are the ones predominantly found in HIV+ patients
(31, 32), and we focused our analysis on DC:Tcon clusters, because
they are the primary site of DC-mediated HIV infection. Of note,
we used a cis-infection model, in which DC were infected and kept
in culture for 3 days before co-culture with Tcon and Treg. Previ-
ous studies have shown that, in this setting, viral particles that are
endocyted and not integrated are rapidly degraded (33, 34). Thus,
it is likely that the viruses detected in our experiments were newly
assembling viral particles at the DC:Tcon IS and not endocytosed
viruses that had been previously assembled, although we cannot
formally exclude the later possibility.
In this model, Treg decreased the frequency of infected
DC:Tcon clusters. Although the effect was modest, it was repro-
ducible in all subjects. This effect was not due to a decreased
frequency of DC:Tcon clusters nor was it due to Treg displac-
ing Tcon from the clusters. Although a prior study reported such
displacement (8), in our hands, Treg did not appear to strictly
disrupt DC:Tcon conjugates. A potential explanation for this dif-
ference is the fact that a higher Tcon:Treg ratio (1:1) was used in
the previous study, while we used the more physiological ratio of
10:1. In contrast, our results are consistent with another report
FIGURE 7 | Decreased actin polymerization and DC maturation
byTreg is the effect most associated with their control of HIV
replication. Comparison of Treg effect and combined CTLA-4/cAMP
blockage on HIV replication, actin polymerization, DC maturation,
and Tcon activation. (A) Blockade of Treg function on HIV infection or
actin polymerization. (B) Blockade of Treg function on HIV infection
or CD83 and CD40 expression. (C) Blockade of Treg function on HIV
infection or CD25 and CD134 expression. Median of 6 (for actin
polymerization) and 7 (for CD83, CD40, CD25, and CD134)
experiment is shown.
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showing that Treg did not decrease the capacity of DC and Tcon
to form clusters, but they impaired the activation of T cells and
their capacity to produce cytokines (35). In our model, Treg also
partially decreased DC maturation; Treg diminished CD40 and
CD83 levels while cytokine production and expression of CD80
and CD86 were not affected. Furthermore, T cell activation was not
significantly changed by Treg. These data are in agreement with a
previous study showing that Treg modestly reduce the expression
of co-stimulatory molecules by DC, but it nevertheless impacted
their ability to activate naïve CD4 T cells (20).
Regulatory T cells also reproducibly impacted actin polymer-
ization and mobility of viruses toward the IS, although, as for DC
activation, their effect was modest. However,even a modest disrup-
tion of HIV transfer due to actin cytoskeleton disruption may have
impact HIV infection because cell-mediated viral transmission is
such a critical step in the spread of HIV infection. Indeed, previ-
ous studies have shown that HIV-1 associates with actin during its
intracellular maturation and assembly, thus favoring virion bud-
ding to the sites where DC and T cells are in contact (36, 37). HIV
motility in infected cells is blocked by actin filament disassembly
following latrunculin treatment (38). In the same line, disruption
of actin or microtubule networks in DC and CD4+ T cells by
specific cytoskeleton inhibitors inhibited DC–T cell interactions
and cell-to-cell HIV spread (22). Interestingly, inhibition of actin
cytoskeleton assembly by Cdc42 blockade did not prevent the for-
mation of DC:T cell clusters, but decreased the transmission of
HIV-1 to CD4 T lymphocytes (39). Additionally, blockage of Rho
GTPase activation, and consequent inefficient actin cytoskeleton
rearrangement, reduced HIV envelope fusion with target cells (40).
Our data suggest that diminished DC maturation and decreased
actin polymerization both contribute to the Treg effect on viral
infection, and they limit cell-mediated viral transfer. The ampli-
tude of the Treg effect in our study was modest, but not very far
from that reported in previous studies. Indeed, it is important to
note even chemical inhibitors of cytoskeleton rearrangement never
achieved full inhibition of HIV transmission. For example, high
doses of latrunculin A resulted in only 25% decrease of cell-to-cell
HIV transmission (41). In another study, treatment of primary
CD4+ T cells with the glycoprotein Slit2, which also affected actin
polymerization, resulted in less than 50% decrease in HIV infec-
tion (42). Similarly, low doses of Cytochalasin D decreased actin
polymerization in DC:CD4 T cell co-cultures, but did not signifi-
cantly decrease the number of DC:T cell aggregates, comparable to
the Treg effect, resulting in a significant decrease of HIV-1 transfer
to T cells by only ~25% (43). Similarly, a small but significant Treg-
mediated decrease of DC maturation could significantly impact
the ability of these DC to activate naïve CD4 T cells (20).
We also studied which molecular mechanisms are used by
Treg to control HIV replication in DC:Tcon clusters. Our results
clearly indicate an involvement of CTLA-4 in Treg activity. CTLA-
4 expression by Treg and interaction with its ligands lead to
decreased DC maturation (8, 24), which could explain the reduced
expression levels of CD83 and CD40 in Treg-containing cultures.
Another possibility is that ligation of Treg CTLA-4 induces their
secretion of TGF-β, which can impair DC maturation (44). TGF-β
can also inhibit expression of molecules important in IS forma-
tion such as ICAM and CD40L (35). Moreover, TGF-β could have
a direct effect on HIV replication (45). However, our preliminary
studies with a blocking anti-TGF-β Ab did not suggest a critical
role for TGF-β in the effect of Treg (data not shown).
Our results also clearly indicate that cAMP is an additional
mechanism used by Treg to control HIV infection. Increased intra-
cellular cAMP levels block virus transfer from DC to CD4+ T
cells (46) and prevent viral release from HIV-infected T cells (47).
cAMP signaling could act at different levels. First, it could affect
DC maturation, as cAMP affects expression of co-stimulatory
molecules by DC and thus their immunogenicity (48). Second,
increased intracellular levels of cAMP in the DC could directly
decrease HIV replication and trafficking. Indeed, cAMP activates
CREB, which competes with NF-κB, thus suppressing the HIV LTR
transcription activity in infected cells (49). Alternatively, cAMP has
been shown to induce HIV lysosomal degradation in immature DC
(46). Downstream of cAMP activation, PKA directly phosphory-
late monomeric actin, which causes a significant decrease in actin
polymerization (50). Consistent with this hypothesis, we found
that treatment of DC:Tcon co-cultures with a cAMP inducing
agent (forskolin) decreased actin polymerization at the IS (Figure
S2 in Supplementary Material). This mechanism could thus con-
tribute to decreased HIV movement to the IS and possibly to its
degradation in the DC.
Taken together, with previous data (14, 15), this new study
shows that Treg can control in vitro HIV infection in all its three
major targets (macrophages, activated T con, and DC), although
the effect on DC was limited. Such a range of targets suggest that
Treg might have a cumulative effect, as they could act on different
steps of the viral life cycle. However, it remains uncertain whether
Treg can decrease HIV replication in vivo. This role is suggested
by the fact that anti-CTLA-4 treatment of SIV-infected macaques
during the acute phase led to enhanced viral replication (51). Sim-
ilarly, treatment of chronically infected African-green monkeys by
Ontak (IL-2R-diphtheria toxin) increased viral load (52), although
it is unlikely that Treg depletion was the only mechanism involved
in these results. Accordingly, expansion of Treg in exposed non-
infected individuals has been hypothesized to contribute to their
resistance to infection (53). Similar protective function of Treg
expansion has also been reported during the acute phase of SIV
infection of SHIV-vaccinated macaques or African-green monkeys
(54, 55). In addition to their effect on viral replication, Treg con-
trol of immune responses, including DC activation, could mediate
protection of the host from tissue damages due to exacerbated
immune responses to viral antigens. This effect was shown in
a murine model of neuro-AIDS (14) and was reminiscent of a
similar role played by Treg in other viral infections (56, 57).
AUTHOR CONTRIBUTIONS
Maria E. Moreno-Fernandez and Jara J. Joedicke performed exper-
iments and analyzed the data; Maria E. Moreno-Fernandez and
Claire A. Chougnet designed the experiments and wrote the
manuscript.
ACKNOWLEDGMENTS
This work was supported by Public Health Service grants
AI068524 (to Claire A. Chougnet), the Distinguished Dissertation
Completion Fellowship and Albert Ryan Fellowship (to Maria E.
www.frontiersin.org May 2014 | Volume 5 | Article 199 | 9
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Moreno-Fernandez et al. Treg diminish HIV infection in DC–Tcon clusters
Moreno-Fernandez), and by the DFG, German Research Founda-
tion with a stipend (GRK1045) (to Jara J. Joedicke). The authors
acknowledge the partial support provided by the Center for Excel-
lence in Molecular Hematology Grant 1P30DK090971-01 and
Digestive Health Center Grant AR47363. The funders had no role
in study design, data collection and analysis, decision to publish, or
preparation of the manuscript. We thank the NIH AIDS Research
and Reference Reagent Program for the IL-2, cell lines, and HIV
lab strain BaL. We thank Dr. Cimarelli for kindly providing SIV-
macVLP plasmid and Dr Chen, Mount Sinai Medical School, for
kindly providing iGFP-HIV plasmids. We also thank Dr. Hildeman
and Dr. Janssen for their critical reading of the manuscript as well
as their expert assistance in analyzing the imaging flow cytometry
data.
SUPPLEMENTARY MATERIAL
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abstract
Figure S1 |The effect ofTreg is independent of the use of VLP. (A) DCs were
infected with HIVBaL alone, without VLP for 3 days and cultured with
CFSE-labeled Tcon. Treg were added or not to DC:Tcon cultures at a 1:10:1
(DC:Tcon:Treg) ratio and co-cultured for 24 h. After exclusion of dead cells, the
percentage of HIV-p24Gag+ cells was measured in the gated DC:Tcon
(CFSE+HLADR+). One representative experiment is shown. Percentage of
HIV-p24Gag+ cells is indicated in each panel. INF, infected. (B) Summary of all
experiments (n=6).
Figure S2 | Cytochalasin D and Forskolin treatment decrease actin
polymerization at the immunological synapse in DC:Tcon clusters. The
upper panel shows the effect of Cytochalasin D treatment on actin
polymerization at the DC:Tcon IS. The lower panel shows the effect of Forskolin
treatment on actin polymerization at the DC:Tcon IS.
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